Publications by authors named "Devvrat Patel"

Claim this Profile
N
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.
Mark Donnelly, Lanyan Fang, Rajanikanth Madabushi, Hao Zhu, Markham Luke, Devvrat Patel

Clin Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of imprecision in incurred sample reanalysis for small molecules.
Sriram Subramaniam, Devvrat Patel, Barbara M Davit, Dale P Conner

AAPS J· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.
Barbara M Davit, Mei-Ling Chen, Dale P Conner, Sam H Haidar, Stephanie Kim, Devvrat T Patel

AAPS J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Barbara M Davit, Patrick E Nwakama, Gary J Buehler, Dale P Conner, Sam H Haidar, Devvrat T Patel

Ann Pharmacother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications.
Barbara M Davit, Dale P Conner, Beth Fabian-Fritsch, Sam H Haidar, Xiaojian Jiang, Devvrat T Patel

AAPS J· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence approaches for highly variable drugs and drug products.
Sam H Haidar, Barbara Davit, Mei-Ling Chen, Dale Conner, LaiMing Lee, Devvrat Patel

Pharm Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis